Viewing Study NCT04930432


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2026-01-01 @ 7:38 AM
Study NCT ID: NCT04930432
Status: RECRUITING
Last Update Posted: 2024-12-27
First Post: 2021-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Sponsor: Betta Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module